Is neutropenia still the main risk factor for invasive aspergillosis? A contemporary university hospital retrospective cohort of invasive aspergillosis in neutropenic and non-neutropenic patients
Risk factors different than neutropenia are currently the most common in IA. The clinical presentation in non-neutropenic patients differs from neutropenic. Resistance to antifungals is emerging especially in breakthrough IA.
Authors
- Alberto Díaz-De Santiago
- Sonia García (ORCID: https://orcid.org/0000-0003-1562-5567)
- Andrea Gutiérrez‐Villanueva
- Elena Múñez (ORCID: https://orcid.org/0000-0002-5256-097X)
- Sara de la Fuente-Moral
- Itziar Diego‐Yagüe
- Edith Gutiérrez-Abreu
- Ana Fernández‐Cruz (ORCID: https://orcid.org/0000-0003-1189-1120)
- Isabel Gutiérrez (ORCID: https://orcid.org/0000-0001-8420-5086)
- Jorge Calderón‐Parra (ORCID: https://orcid.org/0000-0002-0369-9369)
- Alejandro Callejas‐Díaz (ORCID: https://orcid.org/0000-0002-7516-8348)
- Sarela García‐Masedo
- Antonio Ramos-Martínez
- Isabel Sánchez‐Romero
- Nuria Miguel-Ontañón
- Román Fernández-Güitián
- Isabel Castilla-Martínez
- Naomi Bermejo-Moreno
Institutions
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Annals of Clinical Microbiology and Antimicrobials
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1186/s12941-025-00794-8
- Citations
- 3
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 4.19